focus -WSS

focus

author：fashion 2025-10-01 15:29:49 - browse：43482

Several amyloid plaques forming between neurons in a brain — Adobe

Expert advisers to the Food and Drug Administration on Friday voted unanimously in favor of expanding the approval of Leqembi, an Alzheimer’s disease treatment from Eisai and Biogen, further clearing the way for what could be the first widely available medicine that delays the disease’s progress.

The group voted 6-0 that an 1,800-patient study of Leqembi confirmed its benefits for patients in the early stages of Alzheimer’s, recommending the FDA widen the drug’s limited approval. The agency, which is not required to follow the suggestions of its advisers, is expected to make a final decision on Leqembi by July 6.

“I thought the clinical results were robust,” said Merit Cudkowicz, a neurologist from Massachusetts General Hospital and one of the experts invited to review Leqembi.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Hollywood unions extend contract negotiations for actors
Next article： HHS secretary Becerra pressed on Change HealthCare cyberattack

hotspot

WSS

State Dept. review finds Biden bears some blame for Afghanistan failures

John Green on his newest strategy for fighting tuberculosis

Psychedelics group wrestles with new pharma identity

Wildfire smoke exposes gaps in outdoor worker protections

Readout Newsletter: CAR

As AI in medicine takes off, can 'human in the loop' prevent harm?

explore

focus

leisure time

New air purifier tech could be key to improving indoor air quality

Anesthesiologist group: stop taking Ozempic before surgery

In Memoriam: Notable people who died in 2023

HHS secretary Becerra pressed on Change HealthCare cyberattack

How to save PrEP access — and even expand it

As AI in medicine takes off, can 'human in the loop' prevent harm?

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

The high cost of giving birth even with insurance

Anesthesiologist group: stop taking Ozempic before surgery

Continuity nursing helped my family in our darkest PICU moments

knowledge

Ebola: Gilead Sciences antiviral shows promise as new treatment

EPA limits use of carcinogenic gas for sterilizing medical devices

Boston's new lab space is opening empty

DIEP, the 'gold standard' of breast reconstruction, is under threat

UCLA team creates talking throat patch for voice disorders

Readout LOUD podcast: ALS dilemma, first MASH drug, and more

knowledge

hotspot

entertainment

explore